Cardiac Biomarkers

Cardiac markers are measured biomarkers to assess cardiac function. They are often discussed in the context of myocardial infarction, but other conditions can lead to an elevation in the level of cardiac marker. Cardiac biomarkers are elements that are released into the blood when the heart is damaged or strained. Cardiac marker is used in the identification and risk stratification of patients with chest pain and suspected acute coronary syndrome (ACS). These markers include enzymes, hormones and proteins. Cardiac biomarkers have evolved as essential tools in cardiology in the last 50 years, that is, for primary and secondary prevention, the diagnosis and treatment of acute myocardial infarction (AMI), and the diagnosis and stratification of the risk of heart failure. 

  • Cardiac troponin
  • Creatinine kinase (CK)
  • CK-MB
  • Myoglobin

Related Conference of Cardiac Biomarkers

November 07-08, 2018

3rd International Conference on Applied Crystallography

Atlanta, Georgia, USA
January 28-29, 2019

10th Asia Pacific Congress on Polymer Science and Engineering

Seoul, South Korea
February 18-20, 2019

16th Annual Congress on

Materials Research and Technology

Amsterdam, Netherlands
March 11-12, 2019

5th Annual Conference on Biomaterials

Nice, France
March 25-26, 2019

19th International Conference and Exhibition on Materials Science and Engineering

March 25-26, 2019 Yokohama, Japan
April 24-25, 2019

World Congress on Nanomaterials and Nanotechnology

Budapest | Hungary
July 22-23, 2019

35th World Congress on Materials Science and Nanotechnology

Melbourne, Australia

Cardiac Biomarkers Conference Speakers

Recommended Sessions

Related Journals

Are you interested in